HIGHLIGHTS
- who: Quratulain Babar from the Department of Biochemistry Government College University, Faisalabad, Pakistan Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford , BN, United Kingdom have published the article: Novel epigenetic therapeutic strategies and targets in cancer, in the Journal: (JOURNAL)
- what: The strategy of repurposing old drugs - for which crucial information like safety and pharmacokinetic characteristics are already known - for epigenetic-targeting might sidestep the traditional paradigm, in which the primary goal is to create one-indication-only drugs, since epigenetic pathways are common across various cancer models.
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.